Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With <scp>COVID</scp> ‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study
Authors
Henry Pertinez
Tom Fletcher (ORCID: https://orcid.org/0000-0002-3712-415X)
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID ‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study
Henry Pertinez, Tom Fletcher, Orod Osanlou, Thomas Jaki et al.
Journal
Apollo (University of Cambridge)
Topics
COVID-19 Clinical Research Studies
article
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID ‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study
Henry Pertinez, Tom Fletcher, Orod Osanlou, Thomas Jaki, Yvanne Enever, Helen Reynolds, Laura Dickinson, David G. Lalloo, Pavel Mozgunov, Jennifer Gibney, Michelle Tetlow, Elizabeth Challenger, Tim Rowland, Colin Hale, Rebecca Lyon, Margaret Irwin, Justin Chiong, Karim Dhamani, Callum Kelly, William Wood, Laura J Else, Gareth Griffiths, Julian A Hiscox, Geoffrey Saunders, Lauren Walker, Andrew Owen, Saye H Khoo, William Greenhalf, Katie Bullock, Richard FitzGerald, Victoria Shaw, Michael Jacobs